Galnon

Galnon

SCHEMBL4464884

Cc1cc(=O)oc2cc(NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC3CCCCC3)NC(=O)OCC3c4ccccc4-c4ccccc43)ccc12

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TLR2 O60603 4/20 0.44
▸ SLC17A5 Q9NRA2 1/20 0.42
▸ ALDH1A1 P00352 5/20 0.41
▸ KDM4E B2RXH2 4/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ GAA P10253 1/20 0.41
▸ HPGD P15428 4/20 0.40
▸ HSD17B10 Q99714 3/20 0.40
▸ RAB9A P51151 3/20 0.40
▸ NPC1 O15118 2/20 0.40
▸ TDP1 Q9NUW8 2/20 0.40
▸ CASP3 P42574 1/20 0.40
▸ SENP8 Q96LD8 1/20 0.40
▸ SENP7 Q9BQF6 1/20 0.40
▸ SENP6 Q9GZR1 1/20 0.40
▸ HDAC4 P56524 2/20 0.39
▸ MEF2D Q14814 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Galnon SCHEMBL29711017 1.00 TLR2 (0.44) TLR2SLC17A5ALDH1A1KDM4ESMN1; SMN2
Galnon SCHEMBL6834012 1.00 TLR2 (0.44) TLR2SLC17A5ALDH1A1KDM4ESMN1; SMN2
SCHEMBL10144189 0.90 CA1 (0.43) TLR2SLC17A5ALDH1A1KDM4ESMN1; SMN2
SCHEMBL10144324 0.88 TLR2 (0.44) TLR2HDAC4MEF2DCPB2EP300
SCHEMBL10144186 0.87 TLR2 (0.44) TLR2HDAC4MEF2DCPB2EP300
SCHEMBL10143521 0.86 TLR2 (0.43) TLR2HDAC4MEF2DCPB2EP300
SCHEMBL10143403 0.86 TLR2 (0.42) TLR2HDAC4MEF2DCPB2EP300
SCHEMBL10143779 0.86 TLR2 (0.45) TLR2HDAC4MEF2DCPB2EP300
SCHEMBL10144195 0.86 TLR2 (0.44) TLR2HDAC4MEF2DCPB2EP300
SCHEMBL10144161 0.85 TLR2 (0.41) TLR2HDAC4MEF2DCPB2EP300

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009040023-A2 USE OF GALNON AS A THERAPEUTIC AGENT MONDOBIOTECH LABORATORIES AG (LI) 2009-04-02 — — WO disclosed
Send feedback